WallStreetZenWallStreetZen

NASDAQ: GPCR
Structure Therapeutics Inc Stock Ownership - Who owns Structure Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Structure Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Xichen LinCHIEF SCIENTIFIC OFFICER2026-06-2523,634$0.34
$8.04kBuy
Crespo Blas CollCHIEF MEDICAL OFFICER2026-03-0311,826$20.99
$248.23kSell
Ashley HallChief Development Officer2026-03-034,836$20.99
$101.51kSell
Xichen LinCHIEF SCIENTIFIC OFFICER2026-03-0318,735$20.99
$393.25kSell
Jun YoonCHIEF FINANCIAL OFFICER2026-03-0322,305$20.99
$468.18kSell
Yingli MaCHIEF TECHNOLOGY OFFICER2026-03-0311,313$20.99
$237.46kSell
Raymond C. StevensCHIEF EXECUTIVE OFFICER2026-03-0353,454$20.99
$1.12MSell
Ashley HallChief Development Officer2025-09-186,021$7.74
$46.62kSell
Crespo Blas CollCHIEF MEDICAL OFFICER2025-09-188,106$7.74
$62.76kSell

1 of 1

GPCR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GPCR insiders and whales buy or sell their stock.

GPCR Shareholders

What type of owners hold Structure Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC3.94%8,403,449$449.16MInstitution
Wellington Management Group LLP3.41%7,260,287$388.06MInstitution
Avoro Capital Advisors LLC3.07%6,555,555$350.39MInstitution
Fil Ltd3.04%6,473,761$346.02MInsider
Janus Henderson Group PLC2.51%5,354,981$286.22MInstitution
Fmr LLC2.36%5,031,181$268.92MInsider
Deep Track Capital LP2.01%4,279,848$228.76MInstitution
Bvf Inc1.62%3,459,358$184.90MInstitution
Ramy Farid1.53%3,260,495$174.27MInsider
Jun Yoon1.39%2,956,242$158.01MInsider

1 of 3

GPCR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GPCR31.31%10.35%Net SellingNet Buying
DYN84.70%15.30%Net SellingNet Selling
RCUS67.90%32.10%Net SellingNet Selling
CPRX84.26%15.74%Net Buying
BEAM86.61%13.39%Net SellingNet Selling
View Top Biotech Stocks

Structure Therapeutics Stock Ownership FAQ

Who owns Structure Therapeutics?

Structure Therapeutics (NASDAQ: GPCR) is owned by 31.31% institutional shareholders, 10.35% Structure Therapeutics insiders, and 58.34% retail investors. Fil Ltd is the largest individual Structure Therapeutics shareholder, owning 6.47M shares representing 3.04% of the company. Fil Ltd's Structure Therapeutics shares are currently valued at $346.02M.

If you're new to stock investing, here's how to buy Structure Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.